Work

Supplemental Figure 3 from CDK4 Amplification Reduces Sensitivity to CDK4/6 Inhibition in Fusion-Positive Rhabdomyosarcoma

Year: 2023

Type: supplementary-materials

Abstract: Supplemental Figure 3. Further evaluation of CDK4/6 inhibitor sensitivity in fusion-positive and fusion-negative RMS cells.

DOI: 10.1158/1078-0432.22458914.v1

Authors: Mary E. Olanich, Wenyue Sun, Stephen M. Hewitt, Zied Abdullaev, Svetlana D. Pack, Frederic G. Barr

Language: English

Topic: Sarcoma Diagnosis and Treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4361918540

Cites:

Cited by:

Related to: 10